Preventing non-communicable diseases using pricing policies

· ·
· RTI Press
eBook
12
페이지
적용 가능
검증되지 않은 평점과 리뷰입니다.  자세히 알아보기

eBook 정보

Preventing non-communicable diseases (NCDs) in an effective and sustainable way will require forward-looking policy solutions that can address multiple objectives. This was true pre–COVID-19 and is even more true now. There are already examples from across the globe and within the United States that show how these may be possible. Although there are still many unknowns around how the design, targeting, level, sequencing, integration, and implementation of fiscal policies together can maximize their NCD prevention potential, there is already clear evidence that health taxes and particularly sugar-sweetened beverage (SSB) taxes are cost-effective.


Nonetheless, policies alone may not succeed. Political will to prioritize well-being, protections against industry interference, and public buy-in are necessary. If those elements align, pricing policies that consider the context in question can be designed and implemented to achieve several goals around reducing consumption of unhealthy SSBs and foods, narrowing existing nutritional and health disparities, encouraging economic and social development. The US and its local and state jurisdictions should consider these pricing policy issues and their contexts carefully, in collaboration with community partners and researchers, to design multi-duty actions and to be prepared for future windows of opportunities to open for policy passage and implementation.

저자 정보

Shu Wen Ng, PhD, is Distinguished Scholar in Public Health Nutrition and an associate professor in the Department of Nutrition at the Gillings School of Global Public Health and the Carolina Population Center at University of North Carolina at Chapel Hill

Senior Fellow, Health Economics and Financing

Education

PhD, Economics, Northwestern University

MA, Economics, Northwestern University

BA, Economics, Carleton College

Thomas Hoerger, PhD, specializes in health economics, health care reform, and cost-effectiveness analysis and is the director of the Public Health Economics Program at RTI. Dr. Hoerger has led numerous research projects for the Centers for Disease Control and Prevention (CDC) and the Centers for Medicare and Medicaid Services (CMS). He has developed models for examining the cost-effectiveness of health promotion interventions and estimated the costs of diabetes, vision loss, and other conditions. He has directed a series of projects to design, implement, and evaluate competitive bidding for Medicare services. The purpose of the CDC-sponsored RTI-UNC Center of Excellence in Health Promotion Economics, which Hoerger directed, was to develop, evaluate, and implement health promotion recommendations, programs, and policies; to evaluate their cost-effectiveness; and, consequently, to improve upon efforts to promote health and prevent disease, disability, and injury.

Vice President, Global Noncommunicable Diseases

Education

PhD, The George Washington University

M.Phil., The George Washington University

Rachel Nugent, PhD, has more than 30 years of experience in global development as a researcher, practitioner, and policy advisor to governments. She leads a team charged with providing policy analysis, implementation, and evaluation of cost-effective strategies to prevent and control global noncommunicable diseases (NCDs). RTI’s global NCD experts generate and translate new evidence to help guide global and national decision-making aimed at noncommunicable disease detection, prevention, and control. In an effort to reduce premature mortality from these diseases, Dr. Nugent will coordinate capabilities including health economics and evaluation; communication and behavior change; epidemiology and survey research; establishment of disease and risk factor registries; and development of guidelines, care pathways, and medical technology applications for global NCDs.

Dr. Nugent is a member of the Lancet Commission on Noncommunicable Diseases and Injuries of the Poorest Billion, the U.S. Institute of Medicine Committee on Economic Evaluation, and the International Expert Group for the Global Nutrition Report. She also works with the World Health Organization Global Coordination Mechanism Working Group on Noncommunicable Disease Financing and is on the External Advisory Committee of the NCD Alliance and Children’s Heartlink.

Dr. Nugent's interests include the economic benefits of controlling antimicrobial resistance. She was the lead author and chair of The Race Against Drug Resistance, a 2010 report from the Center for Global Development’s expert working group on global drug resistance. The report produced four high-level recommendations to combat antimicrobial and other forms of drug resistance in diseases especially affecting poor countries, and it has been used extensively by the media and government agencies to guide the development of solutions to the epidemic of drug resistance globally.

Previously, Dr. Nugent was an associate professor of global health at the University of Washington and director and principal investigator of the Disease Control Priorities Network. She previously worked at the Center for Global Development, the Population Reference Bureau, the Fogarty International Center of NIH, and the Food and Agriculture Organization of the United Nations.  

이 eBook 평가

의견을 알려주세요.

읽기 정보

스마트폰 및 태블릿
AndroidiPad/iPhoneGoogle Play 북 앱을 설치하세요. 계정과 자동으로 동기화되어 어디서나 온라인 또는 오프라인으로 책을 읽을 수 있습니다.
노트북 및 컴퓨터
컴퓨터의 웹브라우저를 사용하여 Google Play에서 구매한 오디오북을 들을 수 있습니다.
eReader 및 기타 기기
Kobo eReader 등의 eBook 리더기에서 읽으려면 파일을 다운로드하여 기기로 전송해야 합니다. 지원되는 eBook 리더기로 파일을 전송하려면 고객센터에서 자세한 안내를 따르세요.